S07-2010

• CAT Number: I043325
• CAS Number: 1223194-71-5
• Molecular Formula: C19H21N3O3S
• Molecular Weight: 371.45
• Purity: ≥95%
• Synonyms: 7-[2-[(6-oxo-4-propyl-1H-pyrimidin-2-yl)sulfanyl]acetyl]-1,3,4,5-tetrahydro-1-benzazepin-2-one
• InChI: InChI=1S/C19H21N3O3S/c1-2-4-14-10-18(25)22-19(20-14)26-11-16(23)13-7-8-15-12(9-13)5-3-6-17(24)21-15/h7-10H,2-6,11H2,1H3,(H,21,24)(H,20,22,25)
• InChIKey: WVRKQDZPZOUPNW-UHFFFAOYSA-N
• SMILES: CCCC1=CC(=O)NC(=N1)SCC(=O)C2=CC3=C(C=C2)NC(=O)CCC3

S07-2010（Cat No.:I043325）is a selective inhibitor of the protease enzyme cathepsin L, which plays a significant role in various biological processes, including protein degradation, immune regulation, and tissue remodeling. Cathepsin L is implicated in several diseases, such as cancer, neurodegenerative disorders, and cardiovascular conditions. By inhibiting cathepsin L, S07-2010 aims to disrupt these pathological processes, potentially reducing tumor progression, inflammation, and tissue damage. This compound is being investigated for its therapeutic potential in treating cancer, fibrosis, and other diseases characterized by abnormal protease activity and tissue degradation.